JDRF Blog

Latest in Research News

  • JDRF Research Strategy: Cures and Improving Lives

    May 31, 2019

    They shared new developments and applauded the speed of scientific advancements. At this year’s Strategic Research Session, the tone was dynamic as...

  • New JDRF-Funded Study finds Lifetime T1D Management Costs a Collective $813 Billion

    February 24, 2020

    Cost for each diagnosed American is nearly $500,000.

  • ATTD Conference Brings Together Top Minds in Diabetes Research

    February 19, 2020

    Each year diabetes researchers from all over the world gather for the annual meeting of the Advanced Technologies & Treatments for Diabetes...

  • JDRF Awards World-Renowned T1D Researchers

    February 4, 2020

    JDRF is honored to recognize five leading international researchers whose work has and is transforming type 1 diabetes (T1D) science. We also...

  • Universal Screening for Type 1 Diabetes: Its Time has Come?

    January 28, 2020

    Universal screening for type 1 diabetes (T1D) is a priority for JDRF, but the cost versus benefits remain unclear. Now, a large-scale...

  • JDRF and Gore Invest in Development of Implantable Insulin Delivery System

    January 22, 2020

    PhysioLogic Devices, a JDRF-funded company that is dedicated to transforming the treatment of type 1 diabetes (T1D), wants to develop the ThinPump™—a...

  • Can Prozac Prevent Severe Low Blood Sugar?

    January 13, 2020

    Low blood sugar, called hypoglycemia, occurs in over 90 percent of people with type 1 diabetes (T1D). It can usually be detected...

  • FDA Grants Breakthrough Device Status: iLet Bionic Pancreas

    December 23, 2019

    Earlier this week, Beta Bionics announced that the Food and Drug Administration (FDA) has granted breakthrough device designation to the company’s iLet...

  • FDA Authorizes a Second Artificial Pancreas System

    December 13, 2019

    The Food and Drug Administration (FDA) today authorized an algorithm that enables the second artificial pancreas system: The Control-IQ™ advanced hybrid closed...

  • Production of Insulin in People with Type 1 Diabetes

    November 25, 2019

    Sernova, a clinical-stage regenerative medicine company, has shown in its JDRF-funded clinical trial that its cell replacement therapy, the Cell Pouch System™,...